On Thursday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Levy Attainment Corp. (NASDAQ:LEVY), Sabre Corporation (NASDAQ:SABR), Domtar Corporation (NYSE:UFS), WaferGen Bio-systems, Inc. (NASDAQ:WGBS)

Levy Attainment Corp. (NASDAQ:LEVY), with shares gained 2.84%, closed at $11.58.

Sabre Corporation (NASDAQ:SABR), with shares jumped 2.82%, settled at $23.67, hitting new 52-week high of $23.80.

Domtar Corporation (NYSE:UFS), with shares climbed 2.54%, and closed at $46.78.

WaferGen Bio-systems, Inc. (NASDAQ:WGBS), surged 6.83%, and closed at $4.38.

Latest NEWS regarding these Stocks are depicted underneath:

Levy Attainment Corp. (NASDAQ:LEVY)

Levy Attainment Corp. (LEVY), and Del Taco Holdings, Inc. declared that Del Taco has closed its formerly declared recapitalization, in advance of the planned attainment of the Corporation by LAC. Restaurateur Larry Levy, the CEO and Chairman of the Board of LAC, together with his family and a group of new investors have made a private investment of $120 million in the ordinary stock of Del Taco and now own about 46% of Del Taco. Mr. Levy has assumed the Chairmanship of Del Taco while Ari Levy and Steve Florsheim, both officers and directors of LAC, have also joined the Del Taco Board of Directors.

With the completion of the recapitalization, Del Taco has eliminated its subordinated debt and reduced its total debt together with the associated cost of borrowing.

The Corporation’s recapitalization represents the completion of the first step of a two-step process in the merger of a partner of LAC with and into Del Taco, which is predictable to be accomplished in June 2015. In anticipation of that merger, LAC recently declared that Patrick Walsh and Eileen A. Aptman would be joining its Board of Directors upon closure of the merger.

Ms. Aptman is the Chief Investment Officer of Belfer Administration, LLC (“Belfer”) and has served as a director and audit committee member of public and private companies. Associates of Belfer are also part of the investors assembled to fund the recapitalization

Levy Attainment Corp. does not have noteworthy operations. It intends to complete a business combination with an operating corporation in the restaurant and hospitality sectors. The corporation was founded in 2013 and is based in Chicago, Illinois.

Sabre Corporation (NASDAQ:SABR)

Sabre Corporation (SABR), has become the first marketplace to offer automated Round the World (RTW) and Circle Trip (CT) airfares – those that start and end in the same destination, but comprise more than one stop-over.

Developed in partnership with global airline alliance, SkyTeam, and Airline Tariff Publishing Corporation (ATPCO), the new industry standard for purchasing RTW and CT fares assists reduce administrative costs associated with updating and managing RTW products.

Until now, when booking multi-destination RTW itineraries for travelers, agents had to manually add up the prices of each segment of a passenger’s journey. New Sabre technology automates this process, providing a complete fare price to the agent for the passenger’s entire journey. Agencies will also benefit from reduced Agency Debit Memo costs (ADMs), sent by airlines when there is a discrepancy between the fare offered and the airline’s published price. This new capability will be right away accessible for SkyTeam’s Go Round the World (RTW) and Go Round Asia & Southwest Pacific fares.

Sabre Corporation provides technology solutions to the travel and tourism industry worldwide. It operates in two segments: Travel Network, and Airline and Hospitality Solutions. The Travel Network segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, counting airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators, with a network of travel buyers comprising online and offline travel agencies, travel administration companies, and corporate travel departments.

Domtar Corporation (NYSE:UFS)

Domtar Corporation (UFS), declared an investment by Schlumberger in CelluForce, a joint venture between Domtar and FPInnovations that manufactures wood-derived nanocrystalline cellulose (NCCTM). The investment is a partnership to explore the use of NCC to enhance the productivity of oil and gas wells. Schlumberger is the world’s leading supplier of technology, integrated project administration and information solutions to the oil and gas industry.

NCC is manufactured using a patented process in the world’s first facility of its kind, located at Domtar’s pulp mill in Windsor, Quebec . NCC (also referred to as Cellulose Nanocrystals, or CNC) is the primary component that provides structural strength to trees. NCC is a renewable, biodegradable, nontoxic material.

Details of Schlumberger’s investment in CelluForce remain confidential.

“Innovation is one of our core values at Domtar, so we are happy to have the opportunity to collaborate with Schlumberger, a recognized technology innovator in hydrocarbon recovery and production,” said Patrick Loulou , Domtar’s Senior Vice President for Corporate Development and a member of CelluForce’s board of directors.

Domtar Corporation designs, manufactures, markets, and distributes communications papers, specialty and packaging papers, and absorbent hygiene products in the United States, Canada, Europe, Asia, and internationally. It operates in two segments, Pulp and Paper, and Personal Care.

WaferGen Bio-systems, Inc. (NASDAQ:WGBS)

WaferGen Bio-systems, Inc. (WGBS), declared an important industrial partnership with Procter & Gamble whereby Procter & Gamble will utilize WaferGen’s SmartChip MyDesign(TM) quantitative PCR System to conduct various gene expression and other studies.

As the amount of genomics data raises with the use of Next Generation Sequencing (NGS) and microarrays, the need for high-throughput target validation becomes more acute. WaferGen’s SmartChip platform offers two products that enhance these efforts, SmartChip MyDesign(TM) for qPCR and SmartChip TE(TM)for NGS sample preparation.

Relative to competitive offerings, WaferGen believes that the SmartChip MyDesign(TM) System has best-in-class flexibility, high levels of sensitivity without the need for pre-amplification and a very low cost per reaction. WaferGen formerly declared successful proof-of-concept studies utilizing their SmartChip technology for single cell analysis, and intends to offer an Early Access Program in the second quarter of 2015, followed by a commercial product launch before the end of 2015. The single cell offering will provide an important broadening of the platform’s utility, with integrated workflows into NGS and quantitative PCR.

WaferGen Bio-systems, Inc. develops, manufactures, and sells systems for gene expression quantification, genotyping, and stem cell research for the life sciences and pharmaceutical drug discovery industries in the United States, Canada, Europe, and the Asia Pacific.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.